Myocardial dysfunction after out-of-hospital cardiac arrest: predictors and prognostic implications

Yuan Yao1, Nicholas James Johnson2, Sarah Muirhead Perman3

  • 1Grand Strand Health, Myrtle Beach, USA.

Insights

Nearly half of out-of-hospital cardiac arrest patients experience early myocardial dysfunction. Clinical factors like heart failure history and witnessed arrest predict dysfunction, but it doesn't impact survival or neurological outcomes.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Critical Care Medicine

Background:

  • Myocardial dysfunction is a potential complication following out-of-hospital cardiac arrest (OHCA).
  • Understanding its incidence, risk factors, and impact on patient outcomes is crucial for clinical management.

Purpose of the Study:

  • To determine the incidence of early myocardial dysfunction after OHCA.
  • To identify risk factors associated with its development.
  • To examine the association between early myocardial dysfunction and survival/neurologic outcomes.

Main Methods:

  • Retrospective chart review of OHCA patients undergoing echocardiography within 24 hours of return of spontaneous circulation (ROSC).
  • Myocardial dysfunction defined as left ventricular ejection fraction < 40%.
  • Multivariate analysis used to identify risk factors and associations with outcomes.

Main Results:

  • 44% of 190 OHCA patients exhibited early myocardial dysfunction.
  • Factors associated with dysfunction included congestive heart failure history, male gender, witnessed arrest, multiple epinephrine doses, defibrillations, longer resuscitation, and therapeutic hypothermia.
  • Early healthcare provider CPR was associated with lower odds of dysfunction.
  • No significant association found between early myocardial dysfunction and mortality or neurological outcome.

Conclusions:

  • Early myocardial dysfunction is common after OHCA.
  • Several clinical factors can help predict its occurrence.
  • Despite its prevalence, early myocardial dysfunction does not appear to affect neurologically intact survival.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
316
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
550
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
963
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
634
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.7K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
970